Nadia Dac
CIK: 0001773151
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Dac Nadia
Dac Nadia (SEC CIK 0001773151) files insider reports with the SEC as Chief Commercial Officer of Kyverna Therapeutics, Inc. (KYTX).
Signal8 holds 2 ownership filings by Dac Nadia (1 Form 3, 1 Form 4), filed on May 6, 2026. Those filings report 1 transaction, the latest on May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dac Nadia's filings is in EMERYVILLE, CA.
Recent filings by Dac Nadia
- May 4, 2026: Grant or award of KYTX derivative securities (Form 4, code A).
Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)
- CLARK IAN T, Director
- Cohen Fred E, Director
- SEIDENBERG BETH C, Director
- Shaw Christi, Executive Chairperson
- Aktar Mert, Director
- Martini Gregory S., Chief Financial Officer